Cargando…
Promoting remyelination in multiple sclerosis
The greatest unmet need in multiple sclerosis (MS) are treatments that delay, prevent or reverse progression. One of the most tractable strategies to achieve this is to therapeutically enhance endogenous remyelination; doing so restores nerve conduction and prevents neurodegeneration. The biology of...
Autores principales: | Cunniffe, Nick, Coles, Alasdair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815564/ https://www.ncbi.nlm.nih.gov/pubmed/31190170 http://dx.doi.org/10.1007/s00415-019-09421-x |
Ejemplares similares
-
Remyelination varies between and within lesions in multiple sclerosis following bexarotene
por: Brown, J. William L., et al.
Publicado: (2022) -
Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Jolanda Münzel, E., et al.
Publicado: (2013) -
Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007) -
Remyelination in humans due to a retinoid‐X receptor agonist is age‐dependent
por: McMurran, Christopher E., et al.
Publicado: (2022) -
The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019)